ITM XY
Alternative Names: ITM-XYLatest Information Update: 08 Oct 2024
At a glance
- Originator ITM Solucin
- Class Antineoplastics; Drug conjugates; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Cancer
Most Recent Events
- 09 Sep 2024 Phase-I clinical trials in Cancer (unspecified route) (ITM Solucin pipelines; September 2024)